Comment on: "Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide"...Li H-Y, Cheriyan J, Chan T-K, et al. American Journal of Cardiovascular Drugs. 2026;26(1):107-120.
This article focuses on a trial sequential analysis (TSA) conducted to evaluate the robustness of colchicine’s effect on major adverse cardiovascular events (MACE) in cardiovascular disease (CVD) populations, based on a prior meta-analysis of 14 randomized controlled trials. The TSA found that while...
| Publicado en: | American Journal of Cardiovascular Drugs Vol. 26; no. 4; pp. 507 - 510 |
|---|---|
| Autores principales: | , , , |
| Formato: | commentary letter tables/charts Journal Article |
| Publicado: |
Springer Nature
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |